drugset / Trial / NCT07425899
A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult Participants
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a Phase 1 study to investigate safety and pharmacokinetics of ABBV-722 and Upadacitinib following multiple oral doses in healthy adult participants.
Timeline
- Start
- 2026-02-26
- Primary completion
- 2026-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-722 | Unknown | — | Oral |
| Subject | Upadacitinib | Small molecule | — | Oral |
Indications
No indication recorded.